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ABSTRACT 
Hutchinson-Gilford progeria syndrome (HGPS) is a dominant autosomal premature aging 
syndrome caused by the expression of a truncated prelamin A designated progerin. A-type and B-
type lamins are intermediate filament proteins that polymerize to form the nuclear lamina 
network apposed to the inner nuclear membrane of vertebrate somatic cells. It is not known if in 
vivo both type of lamins assemble independently or coassemble. The blebbing and 
disorganization of the nuclear envelope and adjacent heterochromatin in cells from patients with 
HGPS is a hallmark of the disease, and the ex vivo reversal of this phenotype is considered 
important for the development of therapeutic strategies. Here we investigated the alterations in 
the lamina structure that may underlie the disorganization caused in nuclei by progerin 
expression. We studied the polymerization of EGFP- and DsRed-tagged wild-type and mutated 
lamins in the nuclear envelope of living cells by measuring fluorescence resonance energy 
transfer (FRET) that occurs between the two fluorophores when tagged lamins interact. Using 
time domain fluorescence lifetime imaging microscopy (tdFLIM) that allows a quantitative 
analysis of FRET signals, we show that wild-type lamins A and B1 polymerize in distinct 
homopolymers that further interact in the lamina. In contrast, expressed progerin coassembles 
with lamin B1 and lamin A to form a mixed heteropolymer in which A-type and B-type lamin 
segregation is lost. We propose that such structural lamina alterations may be part of the primary 
mechanisms leading to HGPS, possibly by impairing functions specific for each lamin type such 
as nuclear membrane biogenesis, signal transduction, nuclear compartmentalization and gene 
regulation. 
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INTRODUCTION 
Lamins are nuclear intermediate filament proteins with a central dimerization domain or rod (Fig. 
1A) that polymerize to form the lamina network underlying the inner nuclear membrane (1). 
Lamina forms a highly stable structure (2) and anchors nuclear pore complexes, heterochromatin 
and regulatory proteins at the nuclear periphery (3). B-type lamins are constitutive whereas A-
type lamins (lamins A and C) which arise from the LMNA gene by alternative splicing (1, 4) are 
expressed only in differentiated cells (5). Lamin A is synthesized as a precursor, prelamin A, that 
terminates with a CAAX motif (4). This motif triggers sequential posttranslational modifications: 
farnesylation of the cysteine, removal of the AAX amino acids by the endoprotease Zmpste24, 
and carboxymethylation of the cysteine (6-8). After completion of these modifications, the last 15 
amino acids of prelamin A, including the modified cysteine, are also cleaved by the Zmpste24 
endoprotease, generating mature lamin A (6-10). The interactions of A- and B-type lamins have 
been investigated by biochemical methods (11-14) and two-hybrid analyses (15) and homotypic 
and heterotypic interactions were detected. Whether in vivo lamins coassemble or assemble 
independently at the membrane-chromatin interface of somatic cell nuclei is unknown. 
 Mutations in the LMNA gene cause a wide array of inherited diseases, including 
myopathies, a partial lipodystrophy, a peripheral neuropathy, and premature aging syndromes 
(16). Hutchinson-Gilford progeria syndrome (HGPS) is a dominant autosomal premature aging 
disease due to the expression of a truncated prelamin A designated progerin. HGPS is most 
commonly caused by a point mutation in exon 11 of LMNA that activates a cryptic donor splice 
site (17, 18). This mutation leads to the deletion of 50 amino acids within prelamin A that leaves 
the CAAX motif intact but removes the final endoproteolytic cleavage site. Hence, the mutant 
prelamin A is predicted to undergo post-translational modification of the terminal cysteine that 
will be retained in progerin (19-23). Expression of progerin in cells of subjects with HGPS 
triggers an increase in perimeter length of nuclei with an extensive folding of the nuclear 
envelope, accompanied by a modification of the ultrastructural organization of the lamina and 
chromatin (24). Misshapen nuclei in HGPS have been considered as the cellular disease 
phenotype, whose recovery is used as a test for therapeutic efficiency. This nuclear phenotype is 
reversed upon splicing correction of prelamin A pre-mRNA (25), or by blocking the 
farnesyltransferase (19-23)  
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Here we analyzed the alterations in the lamina structure that may underlie the 
disorganization caused in the nuclear envelope by progerin expression. We studied the 
interactions between EGFP- and DsRed-tagged wild-type and mutated lamins in the nuclear 
envelope of living cells by measuring fluorescence resonance energy transfer (FRET), using a 
quantitative method, time domain fluorescence lifetime imaging microscopy (tdFLIM). We first 
studied the interactions of wild-type A- and B-type lamins, in an attempt to establish a putative 
model of their assembly in the lamina. We then used the same approach to analyze how tagged-
progerin integrates and/or disturbs the lamina network.  
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RESULTS  
tdFLIM is an appropriate method to study lamin-lamin interactions in living cells 
We used tdFLIM to detect energy transfer between lamins tagged with EGFP and DsRed 
fluorescent molecules because this method possesses features that are most appropriate for the 
study of protein-protein interactions within polymers. Briefly, when an EGFP-tagged protein 
(donor) interacts with a DsRed-tagged protein (acceptor) in a cotransfected cell, FRET can occur 
if the distance between the two fluorophores is less than 10 nm, leading to a faster fluorescence 
decay of EGFP molecules. The fluorescence lifetime of EGFP molecules involved in FRET 
(τFRET) is shorter than that associated with the EGFP molecules that do not interact with DsRed 
(τEGFP). These two lifetimes allow the calculation of real FRET efficiency (E) through a simple 
equation (E = 1 - τFRET/τEGFP ; see Materials and Methods). The measurement of this E value is 
the basis of the tdFLIM method since differences in E values will only reflect variations in the 
distance/orientation between the fluorescent molecules, but neither the variations in the cellular 
concentration of tagged molecules nor the variations in the relative concentrations of green and 
red species. This property of tdFLIM was essential for the present study because the dilution of 
the exogenous fluorescent lamins by endogenous lamins may vary from cell to cell, as well as the 
relative content in green and red fluorescent lamins. In most of the experiments presented here, 
lamins are tagged at their amino-terminal end (Fig. 1A). Once lamins tagged at this site are 
incorporated in the lamina, the orientation of their fluorophores is expected to be the same. We 
therefore interprete the differences in E values found for various lamin combinations as mostly 
reflecting differences in the distances separating the tagged lamins in the lamina (see Materials 
and Methods). The second basic feature of tdFLIM is that it makes it possible to measure the 
proportion of EGFP-tagged molecules involved in FRET in a given cell. This proportion varies 
depending on two parameters, (i) the ratio of exogenous versus endogenous lamins (unknown at 
the level of individual cells), and (ii) the ratio of acceptor (DsRed) versus donor (EGFP) 
molecules, that is measured through the R/G ratio (see Materials and Methods). In a fraction of 
cells with an unfavorable balance between these two parameters, the probability of a close 
proximity of green and red fluorescent markers is low and FRET is undetectable. The 
measurement at a low R/G value of the fraction of cells with detectable FRET signals allowed us 
to compare the ability of diffent lamins to interact with each other (see below).  
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Overexpressed lamins are integrated within the lamina 
Lamins tagged at their amino-terminal end (Fig. 1A) were transiently expressed in C2C12 
myoblasts. A major characteristic of the nuclear lamina is its resistance to extraction by non ionic 
detergents and salt. We analyzed the resistance to extraction of exogenous and endogenous lamins 
in control C2C12 cells (Fig. 1B, upper panel), and in C2C12 cells overexpressing either DsRed-
lamin A and EGFP-lamin B1 (Fig. 1B, middle panel) or EGFP-progerin (Fig. 1B, lower panel). 
Cells were sequentially extracted with Triton X-100, Triton and salt, and finally digested with 
DNase I and RNase A followed by salt extraction. Supernatants and the final insoluble fraction 
were analyzed by immunoblotting, using antibodies directed against lamins A and C, lamin B1, 
and EGFP. Exogenous lamins were as resistant to extraction as endogenous lamins (Fig. 1B), 
showing that they were integrated within the lamina.  
The localization of the exogenous lamins at the nuclear envelope was confirmed by 
fluorescent microscopy data. In C2C12 cells that contain A- and B-type lamins and in P19 
embryonic cells with only B-type lamins (26), exogenous wild-type and mutated lamins were 
targeted to the nuclear envelope with a pattern indistinguishable from that of endogenous lamins 
(Fig 2). Overexpression of lamin B1 induced in some cells an enlargment of the nucleus with 
nuclear envelope folding (Fig. 2A, arrowheads). A similar increase in size of the nucleus with 
occasional formation of herniations and blebs was observed in some cells overexpressing 
progerin (Fig. 2A, arrows). 
 
Homotypic and heterotypic lamin interactions are detected within the lamina 
We first investigated the occurrence of heterotypic interactions at the nuclear envelope of C2C12 
cells transfected with plasmids encoding EGFP-lamin A and DsRed-lamin B1. Fig. 3A shows that 
the fluorescence decay of EGFP-lamin A at the nuclear envelope was more rapid in cotransfected 
cells (blue curve) than in monotransfected cells (green curve), signaling FRET occurrence. In 
monotransfected cells, the EGFP fluorescence decay was monoexponential with a lifetime (τEGFP) 
of 2.27 ± 0.07 ns (Table 1). In cells coexpressing tagged lamins in which FRET was detectable, 
fluorescence decay became faster due to the appearance of a shorter lifetime. As discussed above, 
this shorter lifetime (τFRET) corresponds to EGFP-lamin A molecules that interact with DsRed-
lamin B1 (see also Materials and Methods). Whatever the lamin combination, DsRed-Lamin 
 7
B1/EGFP-lamin A or DsRed-La A/EGFP-lamin B1, similar values for τFRET and real FRET 
efficiency (E) were obtained (τFRET = 0.76 ± 0.09 ns and E = 0.66 ± 0.04 versus τFRET = 0.80 ± 
0.09 ns and E = 0.65 ± 0.04, respectively) (Table 1). As negative control, we analyzed the 
interactions of lamins with Pom 121, a transmembrane nucleoporin that cannot interact with 
lamins for topological reasons (27). No FRET was detected when EGFP-Pom 121 was 
coexpressed with either DsRed-lamin B1 (Fig. 3B) or DsRed-lamin A (data not shown), whatever 
the levels of expression of lamins and Pom 121. These data that assess the existence of 
heterotypic interactions in the lamina of living cells are in agrement with the data of Moir et al. 
(28) who made similar observations in post-mitotic cells using a qualitative FRET method. 
In cells coexpressing homologous lamins, FRET was also detected (Fig. 3C, Table 1), but 
the EGFP fluorescence lifetime and the corresponding real FRET efficiency of lamin B1 
homotypic interactions (τFRET = 1.00 ± 0.08 ns; E = 0.57 ± 0.04) were distinct from those of 
lamin A homotypic interactions (τFRET = 0.83 ± 0.09 ns; E = 0.64 ± 0.04) (P < 0.0001) and from 
those of heterotypic interactions (see above; Table 1) (P < 0.0001). This difference means that the 
range of distances between lamin B1 molecules in lamina is different from that between lamin A 
molecules or between lamin A and lamin B1 molecules. 
Interactions between exogenous lamins A and B1 were also tested in P19 cells that 
express B-type lamins but not A-type lamins (26). Heterotypic interactions were detected with a 
mean real FRET efficiency value (E = 0.65 ± 0.05) close to the value obtained in C2C12 cells (E 
= 0.65 ± 0.04) (Table 1). The similar FRET efficiency in two cell lines, one of which is devoid of 
endogenous A-type lamins, supports the scaffolding role postulated for B-type lamins in the 
assembly of lamin A (29). It is worth noting that the real FRET efficiency for homotypic lamin 
B1 interactions (E = 0.65 ± 0.05) was higher in P19 cells than in C2C12 cells (E = 0.57 ± 0.04; P 
< 0.0001) (Table 1), indicating that the range of distances between lamin B1 molecules in the 
lamina is different in the two cell lines. This suggests that the structure of lamin B1 polymers 
varies with the composition of the nuclear envelope, and in particular with the level of expressed 
lamin A. The conclusion from this series of experiments is that FRET occurred between 
homologous and heterologous tagged lamins in the lamina of living cells.  
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Lamin-lamin interactions detected by FRET occur within high order polymers 
 Since the first step in lamin polymerization is homodimerization (1, 30), heterotypic lamin A-
lamin B1 interactions detected by FRET were only occurring between homodimers of both types 
in high order polymers. However, a plausible explanation for the homotypic interactions would 
be their occurrence at the very first stage of lamin assembly, within the homodimers. To check 
this possibility, we coexpressed homologous lamins tagged with the two fluorophores and 
analyzed mitotic cells in which the lamina is disassembled into distinct populations of A-type and 
B-type homodimers (30). No FRET was detected indicating that energy transfer did not occur 
within homodimers (data not shown). This suggests that in interphasic cells, FRET occurs 
between dimers within higher order polymers. To strengthen this hypothesis, we analyzed the 
signals generated in the nuclear envelope of interphasic C2C12 cells by coexpression of lamin A 
molecules tagged with EGFP or DsRed at different sites. One lamin A molecule was fused at its 
amino-terminal end to DsRed and another one with EGFP immediately after the rod domain (Fig. 
1A, Intra-EGFP-La A). In a putative homodimer containing both fluorophores, FRET should not 
occur because the two tags would be separated by a distance roughly the length of the rod domain 
(~ 50 nm; see Fig. 1A), i.e. greater than the maximum distance compatible with FRET (10 nm). 
The data showed that FRET was detected between Intra-EGFP-lamin A and DsRed-lamin A with 
an associated lifetime of 0.94 ± 0.14 ns (n = 25). Real FRET efficiency (E = 0.59 ± 0.06) was 
lower than obtained when both tags were present at the amino-terminal end of lamin A (E = 0.64 
± 0.04; P < 0.001). This difference in E values is probably due to different distances between the 
fluorophores in the lamina and to possible distinct orientations related to their locations in lamin 
A. These data demonstrate that FRET signals did not occur between two lamin molecules within 
homodimers, but rather between lamins present in distinct dimers within higher order polymers. 
 
Homotypic interactions are favored over heterotypic interactions 
In cotransfected cells, it was checked if among the different lamin combinations used here some 
were more favorable than others in triggering FRET. The acceptor (DsRed) to donor (EGFP) 
ratio (R/G) was measured in individual cells and found to vary between 2 and 25 (Table 2; see 
Materials and Methods). In cells containing a large excess of acceptor over donor (R/G > 15), 
FRET was detected in all cells, whatever the lamin combination (Table 2). With a lower excess 
of acceptor over donor (R/G < 15), homotypic combinations generated a higher proportion of 
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cells positive for FRET than heterotypic combinations (Table 2, 83% and 93% versus 20%), 
meaning that the threshold for FRET triggering was lower for homotypic interactions. In the 
lamina, homotypic interactions are therefore clearly favored compared to heterotypic interactions. 
 
Integration of progerin within the lamina  
We then assessed how truncated prelamin A (progerin) integrates into the lamina. Figures 1B and 
2A show that both EGFP- and DsRed-tagged progerin molecules are targeted to the nuclear 
envelope in C2C12 cells and incorporated into an extraction-resistant structure. As the toxic 
effect of progerin in cells is dose-dependent (24), FRET analyses were performed at a high level 
of progerin expression with progerin as the acceptor molecule (DsRed-progerin). When the 
tagged progerins were coexpressed, or when DsRed-progerin was expressed with EGFP-tagged 
lamins B1 or A, FRET occurred in all cases, with nearly identical real FRET efficiencies of 0.58 
± 0.07, 0.56 ± 0.07, and 0.59 ± 0.05, respectively (Table 1). Thus, the range of distances in the 
lamina separating progerin molecules from each other, from lamin A, and from lamin B1 is 
identical, supporting an even distribution of these three lamin proteins in the lamina. These 
similar real FRET efficiency values found for progerin interactions were lower than those 
previously found for lamin A interactions with either lamin A (E = 0.64 ± 0.04; P < 0.002) or 
lamin B1 (E = 0.65 ± 0.04; P < 0.0004) (Table 1). In contrast, the E values found for progerin 
interactions were similar to those previously measured for lamin B1 homotypic interactions (E = 
0.57 ± 0.04), indicating that the common range of distances separating lamins A, B1, and 
progerin in the lamina is similar to that previously found between lamin B1 molecules. These 
data suggest that progerin behaves similarly as lamin B1 during lamina assembly. The fact that 
lamin B1 coassembles preferentially with progerin rather than with wild-type lamin A is 
supported by the high proportion of cells in which FRET was detectable when DsRed-progerin 
and EGFP-lamin B1 were coexpressed, compared to the low proportion when DsRed-lamin A 
and EGFP-lamin B1 were coexpressed (62% versus 20%; P < 0.05) (Table 2; R/G < 15). Taken 
together, our data support a model in which progerin would displace a pool of lamin A from 
homopolymers to a heterotypic structure containing also lamin B1 and progerin. 
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DISCUSSION  
We used tdFLIM, a quantitative FRET analysis method, to study alterations in lamin 
polymerization in living cells provoked by the expression of progerin. Since the in vivo homo- or 
heteropolymerization of A- and B-type lamins had not been elucidated, the interactions of wild-
type lamins of both types tagged with EGFP and DsRed were first studied, in an attempt to 
establish a putative model of their assembly in the lamina. Three possible models of lamin 
polymer organization were considered (Fig. 4A). In model 1, A-type and B-type lamins form 
homopolymers that are not in contact. In model 2, A-type and B-type lamins interact within 
heteropolymers where they are evenly distributed. In model 3, A-type and B-type lamins interact 
within polymers where they are not evenly distributed. We then checked with which model the 
FRET data fit the best. Since, as shown here, lamin A and lamin B1 interact, model 1 was 
discarded. An even distribution of lamins of both types into polymers, as in model 2, would have 
provided homogeneous real FRET efficiencies values and similar proportions of FRET positive 
cells at all R/G ratios, whatever the lamin combination. Instead, we obtained different values of 
real FRET efficiencies for the homotypic interactions of lamin A and lamin B1, and a low 
sensitivity for FRET triggered by heterologous combinations of lamins compared to both 
homologous combinations of lamins. These data eliminate model 2 and support model 3 that 
postulates an uneven distribution of lamins in polymers. Model 3 is compatible with either an 
heteropolymeric structure with an uneven distribution of both lamins or the juxtaposition of 
homopolymers of lamin A and lamin B1 in close contact. FRET analysis did not allow us to 
distinguish between these two possibilities, but the existence of homotypic structures of both 
lamin types in living cells supports the latter possibilities. In the nuclei of embryonic and stem 
cells, the lamina is exclusively composed of B-type lamins (5). On the contrary, nuclei in 
cultured fibroblasts of individuals expressing lamin A bearing missense mutations (31, 32) 
develop membrane herniations that contain a lamina structure exclusively composed of A-type 
lamins. Since homopolymerization of A- and B-type lamins were shown by these previous 
studies to occur in living cells and heterotypic interactions of lamins are demonstrated in the 
present study, we favor the model of lamina in which interaction occurs between juxtaposed A-
type and B-type lamin homopolymers. 
We further propose an additional feature of the lamina structure linked to the difference in 
post-translational modifications present at the carboxyl-terminal end of mature lamin B1 and 
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lamin A. B-type lamins are permanently farnesylated at their carboxyl-terminal end (7, 8), while 
this modification occurs only transiently in the process of prelamin A maturation, due to the 
action of the specific membranous endoprotease Zmpste24 (6, 8-10). We suggest that polymers 
of farnesylated B-type lamins associate more closely with the membrane than polymers of A-type 
lamins (Fig. 4B), due to the integration of the hydrophobic farnesyl group within the inner 
nuclear membrane and/or association with a putative isoprenyl-carboxymethyl-lamin receptor 
(33).  
 The same approach was used to analyze how tagged-progerin integrates and/or disrupts 
the lamina network. We showed that progerin can interact with both lamin A and lamin B1, as 
well as with progerin. The observation that real FRET efficiencies are the same for these lamin 
combinations (Table 1) supports an even distribution of the three lamin proteins in the lamina. 
The shared real FRET efficiency value was lower than that previously found for wild-type lamin 
A homotypic and heterotypic interactions, but similar to that measured for lamin B1 homotypic 
interactions. Thus, the range of distances separating progerin and lamins A and B1 in the lamina 
is identical to the range of distances separating lamin B1 molecules in homotypic polymers. 
These data suggest that progerin behaves as lamin B1 during lamina assembly. This conclusion 
was strengthened by the fact that lamin B1 preferentially coassembles with progerin rather than 
with wild-type lamin A (Table 2). Taken together, our data support a model in which progerin 
would displace a pool of lamin A from homopolymers to form a heterotypic structure containing 
evenly distributed lamin B1, progerin and lamin A (Fig. 4C). Expression of progerin would thus 
switch lamina structure from model 3 to model 2 (Fig. 4A). 
This change in lamina assembly may explain how endogenous as well as exogenous 
progerin generate dysmorphic nuclei with extensive nuclear membranes (24, 25) (Fig. 2A). In 
normal cells, the cysteine residue post-translationally modified at the carboxy-terminus of B-type 
lamins is responsible for the growth of the nuclear membrane (34, 35). This may result from the 
insertion of this hydrophobic moiety into the membrane lipid bilayer or by interaction with a 
putative receptor (33). The terminal cysteine modifications are abnormally conserved in progerin 
(20) and may allow this truncated prelamin A to preferentially associate with lamin B1 and 
induce abnormal membrane biogenesis via the same mechanisms. In support with our model, 
similar altered nuclear phenotypes occur in mouse cells that accumulate full-length prelamin A 
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due to a deficiency in the expression of the Zmpste24 endoprotease (6, 9), a reversal of the 
phenotype being achieved by blocking farnesyltransferase (19-23). 
 The assembly of progerin with B-type and A-type lamins in an abnormal network may 
also modify the interactions of these lamins with their respective partners in adjacent structures 
(16, 33, 36). Ultrastructural modifications of the lamina and peripheral heterochromatin are 
observed in nuclei of subjects with HGPS, together with an alteration in the distribution of 
nuclear pore complexes in the nuclear envelope (24). Ultrastructural chromatin abnormalities are 
also present in nuclei from Zmpste24-deficient mice (37). Finally, the loss of A-type and B-type 
polymer segregation may also disturb the interactions of the lamina with various partners, 
generating pleiotropic downstream cellular events such as upregulation of p53 target genes (38), 
defective DNA repair (37), and impairment of DNA replication and transcriptional activity (24), 
finally leading to increased apoptosis and abnormal proliferation (39).  
 The tdFLIM technique is an appropriate method to analyze the changes of lamina 
structure in living cells expressing either progerin or various mutated lamins A responsible for 
numerous severe disorders (16). It also represents a promising quantitative approach to evaluate 
reversal to a normal phenotype in the development of therapeutic strategies.  
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MATERIALS AND METHODS 
Plasmid constructions 
 pEGFP-lamin B1 and POM121-EGFP3 were gifts of Dr. J. Ellenberg (EMBL, Heidelberg). The 
pEGFP-prelamin A construct has been described (40). The pDsRed-lamin A and pDsRed-lamin 
B1 constructs were produced in pDsRed-C1 vectors (Clontech Laboratories, Inc.) with DsRed in 
frame at the amino terminus of the full-length cDNAs of lamins. Intra-EGFP-prelamin A 
constructed was made following a three-step cloning strategy. From the pEGFP-prelamin A 
plasmid, a cDNA encoding the first 414 residues of prelamin A (prelamin A (1-414)) was 
amplified by PCR, with an EcoRI restriction site engineered at the 5’ end of the sense primer (5’-
GCG AAT TCT ATG GAG ACC CCG TCC CAG GGG-3’) and a KpnI site engineered at the 5’ 
end of the antisense primer (5’-GC GGT ACC CCC ACC CTG TGT CTG GGA TGA-3’) 
(restriction sites underlined). The reaction products were digested with EcoRI and KpnI and 
ligated into the EcoRI and KpnI sites of pSVK3 (Amersham Pharmacia Biotech, Inc.) similarly 
digested. From the pEGFP-C1 plasmid, the EGFP cDNA was amplified by PCR, with a KpnI site 
engineered at the 5’ end of the sense primer (5’-GC GGT ACC ATG GTG AGC AAG GGC 
GAG GAG-3’) and a BamH1 site engineered at the 5’ end of the antisense primer (5’-GC GGA 
TCC CTT GTA CAG CTC GTC CAT GCC-3’). The reaction products were digested with 
BamH1 and KpnI and ligated into the BamH1 and KpnI sites of pSVK3-prelamin A (1-414) 
similarly digested. From pEGFP-prelamin A, a cDNA encoding the last 220 residues of prelamin 
A was amplified by PCR, with a BamH1 site engineered at the 5’ end of the sense primer (5’-GC 
GGA TCC AGC GTC ACC AAA AAG CGC AAA-3’) and an Xho1 site engineered at the 5’ end 
of the antisense primer (5’-GC CTC GAG TTA CAT GAT GCT GCA GTT CTG-3’). The 
reaction products were digested with BamH1 and Xho1 and ligated into the BamH1 and Xho1 
sites of pSVK3-prelamin A (1-414)-EGFP similarly digested. 
From pEGFP-prelamin A and pDsRed-prelamin A, the sequence corresponding to a 
region in the carboxy-terminal domain of prelamin A was removed by digestion with SanDI and 
Acc65I and replaced by the DNA sequence specific of progerin (internal deletion of base pairs 
(bp) 1819 to 1968; residues 607 to 656). The dsDNA sequence corresponding to the carboxy-
terminal fragment of progerin was obtained from oligonucleotides synthesized by Proligo Primers 
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and Probes (Proligo France). The first couple of single strand (ss) oligonucleotides was designed 
to correspond to the LMNA gene from bp 1723 to 1772 with a SanDI site in the 5’ end of the 
sense oligonucleotide (sense oligonucleotide : 5’-GAC CCC GCT GAG TAC AAC CTG CGC 
TCG CGC ACC GTG CTG TGC GGG ACC TG-3’; antisense oligonucleotide 5’-TG CCC GCA 
GGT CCC GCA CAG CAC GGT GCG CGA GCG CAG GTT GTA CTC AGC GGG-3’). The 
second couple of ss oligonucleotides was designed to correspond to bp 1773-1818 of the LMNA 
gene followed by bp 1969-1992, extended with CTTA and an Acc651 site at the 5’ end of the 
antisense oligonucleotide (sense oligonucleotide 5’-C GGG CAG CCT GCC GAC AAG GCA 
TCT GCC AGC GGC TCA GGA GCC CAG AGC CCC CAG AAC TGC AGC ATC ATG TAA 
G-3’; antisense oligonucleotide 5’-GT ACC TTA CAT GAT GCT GCA GTT CTG GGG GCT 
CTG GGC TCC TGA GCC GCT GGC AGA TGC CTT GTC GGC AGG C-3’). After duplex 
formation, the two double strand (ds) oligonucleotides were annealed and the purified ds DNA 
sequence (154 bp) was inserted either into the pEGFP-prelamin A or into pDsRed1-prelamin A 
vector previously digested with SanDI and Acc651. 
tdFLIM acquisitions 
The apparatus used for FRET determination performs tdFLIM by the time- and space-correlated 
single photon counting method (41). This method directly gives the picosecond (ps) time-
resolved fluorescence decay for every pixel by counting and sampling single emitted photons 
according to i) the time delay between photon arrival and laser pulse (ps time scale, 4096 
channels), and ii) their xy coordinate (256x256 pixel image). A titanium sapphire laser (Millennia 
5W/Tsunami 3960-M3BB-UPG kit, Spectra-Physics, France) that delivers ps pulses was tuned at 
960 nm to obtain an excitation wavelength at 480 nm after frequency doubling. The repetition 
rate was 4 MHz after pulse-picker (Spectra-physics 3980-35, France). The laser beam was 
expanded and inserted into an inverted epifluorescence microscope (Leica DMIRBE, France) for 
wide field illumination (a few mW/cm2). The microscope stage was equipped with an incubator 
system for temperature and CO2 regulation (37°C, 5 % CO2). Green fluorescence decay images 
were taken using a Leica Plan-Apochromat 100X 1.3NA oil objective, a dichroic beam splitter 
(505DRLP; Omega; Optophotonics, Eaubonne, France), an emission filter (535DF35; Omega; 
Optophotonics, Eaubonne, France), and the quadrant-anode TSCSPC detector (QA, Europhoton 
GmbH, Germany). The band pass emission filter (515 nm < λem < 560 nm) was chosen to select 
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the donor fluorescence (EGFP) and to reject the acceptor fluorescence (DsRed). The count rate 
was up to 50 kHz. Acquisition of fluorescence decay images was done after accumulation of 
sufficient single photon events, usually 3 to 6 min. A temporal resolution of less than 100 ps and 
a spatial resolution of 500 nm were determined previously for this system (41). 
tdFLIM data analysis using a three exponential model 
For qualitative determination of FRET, the fluorescence decays of EGFP within the regions of 
interest were extracted from the acquisition matrix and the decays of EGFP-tagged lamins 
(donor) in the presence of DsRed-tagged lamins (acceptor) were compared with the control 
decays of the EGFP-tagged proteins measured in the absence of acceptor. To perform the 
quantitative analysis of FRET, the experimental fluorescence decays were further deconvoluted 
with the instrument response function and fitted by a Marquardt nonlinear least-square algorithm 
using Globals Unlimited software (University of Illinois at Urbana, Champain) with discrete 
lifetimes as theoretical model.  
 For each tdFLIM experiment, the fluorescence decays of EGFP in cells expressing EGFP-
tagged proteins alone (monotransfected cells) or with DsRed-tagged proteins (cotransfected cells) 
were analyzed. The fluorescence decay of EGFP-tagged proteins in monotransfected cells was 
monoexponential with a lifetime of 2.27 ns ± 0.07 ns in C2C12 cells (n = 136). As the DsRed 
protein emits a weak green fluorescence before maturation in vitro (42) as well as in vivo (43), 
the decays of the green species of DsRed (Supplementary Material, Figure S1) in the 515 and 560 
nm interval were analyzed and found to fit with a 2-exponential model, with lifetimes of 2.30 ± 
0.50 ns and 0.24 ±0.07 ns in C2C12 cells (n = 51), and 2.54 ± 0.26 ns and 0.25 ± 0.02 ns in P19 
cells (n = 17), respectively. These values were consistent with those previously found in vitro and 
in vivo (44, 45). The component with the shorter lifetime was 89 to 96%. In cotransfected cells in 
which the fluorescence decay was more rapid than in monotransfected cells, FRET analyses were 
carried out by fitting the fluorescence decays of EGFP using a 3-exponential model. For C2C12 
and P19 cells, the fluorescence lifetime of free EGFP-lamins (τEGFP) was fixed at 2.27 ns and 
2.26 ns, and that of the major component of the green species of DsRed-lamins (τDsRed) at 0.24 ns 
and 0.25 ns, respectively. The third lifetime corresponding to FRET (τFRET) remained free. In 
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cotransfected cells, the time-dependent fluorescence decay I(t) in the selected area is given by the 
sum:  
I(t) = αEGFP.e-t/τEGFP + αDsRed.e-t/τDsRed + αFRET.e-t/τFRET 
in which αEGFP, αDsRed and αFRET are the corresponding pre-exponential factors. 
Calculation of FRET features 
The proportion of EGFP-tagged proteins involved in FRET corresponds to the ratio  
αFRET / (αEGFP + αFRET)  
The value of this ratio varied as a function of the intensity of the acceptor (DsRed) fluorescence, 
similarly for all couples of lamins analyzed in the present study (see Supplementary Material, 
Figure S2). 
The real FRET efficiency (E) can be calculated by the equation  
E = 1 - τFRET/τEGFP 
E depends on the distance separating the donor and acceptor fluorophores and on their 
orientations. In most of the experiments presented here, lamins are tagged at their amino-terminal 
end (Fig. 1A). Once lamins tagged at this site are incorporated in the lamina, the orientation of 
their fluorophores is expected to be the same. We therefore interprete the differences in E values 
found for various lamin combinations as mostly reflecting differences in the distances separating 
the tagged lamins in the lamina. To a lower τFRET corresponds a higher transfer efficiency, 
indicative of a shorter distance (R) between the chromophores engaged in FRET, following the 
equation: 
E = R06 / (R06 + R6) 
where the Förster distance R0 corresponds to the distance at which 50 % efficiency of energy 
transfer takes place. In the case of fluorophores that move freely, R0 is 4.7 nm for the couple 
EGFP and DsRed (46). 
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The percentage of cells with detectable FRET varies as a function of the acceptor to donor 
expression ratio. The relative quantity of EGFP- and DsRed-tagged proteins in transfected cells 
was calculated from additional green and red fluorescence intensity images acquired using 
appropriate filter cubes, a mercury lamp and a conventional CCD camera (Silar, St Petersburg, 
Russia). The intensities of EGFP (IGFP) and DsRed (IRed) signals were estimated in arbitrary units 
separately for green and red images. The mean gray level of regions of the nuclear envelope was 
calculated by taking into account the exposure time and excitation level, allowing for a 
comparison of the signals between different cells. FRET was measured in cells in which the 
acceptor was in excess over the donor, with a ratio IRed/IGFP (R/G) between 2 and 25. IGFP was 
above 2 (maximum 50) and IRed above 10 (maximum 300). Global analysis of the data shows that 
the 15 value for the R/G ratio divides the data into two classes. Above this value, nearly 100% of 
cells generate FRET signals whatever the lamin combination (Table 2). Below this saturation 
value, the percentage of cells generating FRET signals was highly dependent upon the lamin 
combination (Table 2). Therefore, the latter condition was used to determine if some lamin 
conditions were more favorable than others to trigger FRET. 
 
Cell culture and transfections 
The original mouse myoblast C2C12 cell line was grown in DMEM medium containing 15 % 
fetal calf serum (FCS), 1 mM glutamine, and 1 % antibiotics (100 units/ml penicillin and 100 
µg/ml streptomycin). Mitotic C2C12 cells accumulated by overnight culture in the presence of 40 
ng/ml nocodazole. Mouse embryonic P19 cells were grown in α-MEM medium containing 7.5 % 
FCS and identical additives. Cells grown to 50 % confluency in chamber slides were transfected 
using FuGene6 (Roche Diagnostic Co., Indianapolis, USA) following the manufacturer’s 
instructions. Cells were used 40 to 48 hours after transfection. 
Immunoblotting and fluorescence microscopy 
Both methods were performed as previously described (31, 32, 40). 
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Statistical analysis 
In Table 1, real FRET efficiencies were compared using the Student T-test. Percentages of cells 
positive for FRET (Table 2) were compared using the Chi-square test. 
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LEGENDS TO FIGURES 
 
Figure 1. Overexpressed tagged lamins, wild-type or mutated (progerin) are integrated within the 
lamina. (A) Schematic diagram of the lamins expressed by the plasmid constructs. Numbers refer 
to the amino acids of lamin proteins. The large box represents the dimerization rod domain. The 
small squares and triangles correspond to the EGFP and DsRed fluorophores, respectively. La A, 
La B1 and Pgn refer to lamin A, lamin B1 and progerin, respectively. (B) Endogenous and 
exogenous lamins are similarly resistant to extraction. Control C2C12 cells (upper panels) and 
C2C12 cells coexpressing tagged lamin A (DsRed-La A) and lamin B1 (EGFP-La B1) (middle 
panels), or expressing tagged progerin (EGFP-Pgn) (lower panels), were sequentially extracted 
with Triton X-100 (TX), Triton and salt (TX-NaCl), and finally digested with DNase I and RNase 
A followed by salt extraction (TX-N-DNase). The three supernatants (TX, TX-NaCl, TX-N-
DNase) and the final insoluble fraction (Ins) were analyzed by immunoblotting. In left panels, 
endogenous lamins A and C (La A and La C) and DsRed-lamin A (DsRed-La A) were revealed 
by rabbit antibodies directed against lamins A and C, and EGFP-progerin (EGFP-Pgn) was 
revealed by a monoclonal antibody directed against GFP. In right panels, endogenous lamin B1 
(La B1) and exogenous lamin B1 (EGFP-La B1) were revealed by rabbit antibodies directed 
against lamin B1. Each lane corresponds to material extracted from 5x104 cells. The amount of 
extracted proteins in each fraction (supernatants and pellet), as judged by Ponceau red staining 
(not shown), was similar in all experiments.  
 
Figure 2. Overexpressed tagged lamins localize at the nuclear envelope in C2C12 (A) and P19 
(B) cells. Endogenous lamins A and C (La A/C) and B1 (La B1) are revealed by indirect 
immunofluorescence in C2C12 and in P19 cells, using antibodies against lamins A and C (anti-
LaA/C) and antibodies against lamin B1 (anti-La B1). Note that A-type lamins are not expressed 
in P19 cells. Exogenous EGFP- or DsRed- tagged wild-type lamins and progerin (Pgn), detected 
by direct fluorescence, localize at the nuclear periphery. The nuclei in some C2C12 cells 
expressing progerin are larger than usual and dysmorphic (arrows) with extensive nuclear 
envelope folding (arrowheads). A similar folding is also observed in some cells expressing 
exogenous lamin B1 (arrowheads). Bars = 10 µm.  
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Figure 3. Heterotypic and homotypic interactions between tagged lamins are detected by FRET. 
C2C12 cells were mono- and cotransfected as indicated. Steady-state fluorescence images were 
acquired with a CCD camera (CCD panels). Time integrated images obtained for each cell with 
the quadrant anode detector are presented in the Quadrant panels. Nuclear envelope domains 
(highlighted in yellow in Quadrant panels) were selected, and corresponding fluorescent decays 
are normalized and plotted in the graphs. Green and blue curves refer to fluorescence decays in 
mono- and cotransfected cells, respectively. (A) FRET occurs in cells coexpressing tagged lamins 
A (La A) and B1 (La B1). (B) FRET is not detected in cells coexpressing tagged lamin B1 and 
Pom121. (C) FRET occurs in cells coexpressing EGFP- and DsRed-tagged lamin B1. ns refers to 
nanosecond. Bars = 10 µm. 
 
Figure 4. Hypothetical models of lamina structure represented in a transverse section of the 
nuclear envelope. (A) Schematic cross-sectional representation of possible polymer assembly of 
A- and B-type lamins in the lamina. In model 1, lamins are integrated into homopolymers that are 
not in contact. In model 2, both types of lamins are integrated into mixed polymers where they 
are evenly distributed. In model 3, lamins of both types interact but they are not evenly 
distributed. They are integrated either in a heteropolymeric structure or in two homopolymers 
that are in contact. (B) In a somatic cell, wild-type A- and B-type lamins form homopolymers 
that interact. Due to the insertion of the farnesyl group (squiggly line) into the inner nuclear 
membrane, B-type polymers are more closely associated with the membrane than A-type 
polymers. Since lamina is a fenestrated structure, a fraction of the chromatin is represented in 
contact with the membrane. (C) In a cell expressing progerin, farnesylated progerin assembles 
with B-type lamins to form mix heteropolymers, while homopolymerization of B-type lamins is 
abolished. Since progerin still associates with a fraction of wild-type lamin A, the new mixed 
polymer of lamin B and progerin, also contains lamin A (B-P-A). 
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TABLES 
 
Table 1. FRET lifetimes and real FRET efficiencies in cells expressing EGFP and DsRed tagged 
lamins.  
 
Coexpressed tagged proteins
FRET lifetime 
 τFRET (ns) 
Real FRET efficiency 
E = 1 - τFRET/τEGFP 
Cell 
number
Interphasic C2C12 cells : τEGFP = 2.27 ± 0.07 ns              136  
DsRed-La B1 / EGFP-La A 0.76 ± 0.09 0.66 ± 0.04* 10 
DsRed-La A / EGFP-La B1 0.80 ± 0.09 0.65 ± 0.04* 22 
DsRed-La A / EGFP-La A 0.83 ± 0.09 0.64 ± 0.04* 21 
DsRed-La B1 / EGFP-La B1 1.00 ± 0.08 0.57 ± 0.04 23 
DsRed-Pgn / EGFP-Pgn 0.96 ± 0.17 0.58 ± 0.07** 22 
DsRed-Pgn / EGFP-La B1 1.01 ± 0.16 0.56 ± 0.07** 27 
DsRed-Pgn / EGFP-La A 0.93 ± 0.10 0.59 ± 0.05** 15 
Interphasic P19-EC cells : τEGFP = 2.26 ± 0.02 ns              27 
DsRed-La B1 / EGFP-La B1 0.78 ± 0.12 0.65 ± 0.05*** 30 
DsRed-La A/ EGFP-La B1 0.80 ± 0.13 0.65 ± 0.05 12 
 
FRET lifetimes (τFRET) and real FRET efficiencies (E) in transfected C2C12 and P19 cells. Mean 
τFRET values are expressed in nanoseconds (ns). In each series of experiments, τEGFP is the mean 
of the lifetimes of EGFP in monotransfected cells. For C2C12 and P19 cells, a total of 136 and 27 
nuclei in monotransfected cells were analyzed, as indicated. For each cotransfection, 
monotransfection with the corresponding EGFP-tagged protein was performed. Mean τFRET and E 
values include standard errors.  
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* P < 0.0001 vs DsRed-La B1 / EGFP-La B1 in C2C12 cells 
 
** P < 0.002 vs DsRed-La A / EGFP-La A 
 P < 0.0004 vs DsRed-La A / EGFP-La B1 in C2C12 cells 
 
*** P < 0.0001 vs DsRed-La B1 / DsRed-La B1 in C2C12 cells. 
 
 
 
Table 2. Percentage of cells with detectable FRET as a function of the acceptor (DsRed) to donor 
(EGFP) expression ratio (R/G).  
 
Coexpressed tagged proteins
R/G < 15 
(%) 
R/G >15 
(%) 
DsRed-La A / EGFP-La B1 20 92 
DsRed-La A / EGFP-La A 83 100 
DsRed-La B1 / EGFP-La B1 93 100 
DsRed-Pgn / EGFP-Pgn 100 nd 
DsRed-Pgn / EGFP-La B1 62* 100 
DsRed-Pgn / EGFP-La A nd 100 
DsRed-La A / EGFP-Pgn 69 100 
 
Abbreviations are as in Table 1. The relative quantity of DsRed- and EGFP-tagged proteins in 
transfected cells were calculated from fluorescence intensity measurements as described in 
Materials and Methods. Data were obtained from about 20 cells in each case and expressed as a 
percentage (%) of cells in which FRET was detectable. nd, not determined. Statistical data 
concerning this Table are presented in the text. 
 
* P < 0,05 vs DsRed-La A / EGFP-La B1 
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ABBREVIATIONS 
 
FRET, fluorescence resonance energy transfer; FLIM, fluorescence lifetime imaging microscopy; 
tdFLIM, time domain FLIM; HGPS, Hutchinson-Gilford progeria syndrome; CAAX, cysteine, 
aliphatic, aliphatic, one of several amino acids; EGFP, enhanced green fluorescent protein; 
DsRed, red fluorescent protein; n, number of nuclei. 
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